Antisense oligomers targeting HOXB-AS3 lon non-coding RNA

Ramiro Garzon; Adrienne Dorrance; Dimitrios Papaioannou; Robert Lee; Sakari Kauppinen; Andreas Petri; Charlotte Albæk Thrue

Antisense oligomers targeting HOXB-AS3 lon non-coding RNA

Ramiro Garzon (Inventor), Adrienne Dorrance (Inventor), Dimitrios Papaioannou (Inventor), Robert Lee (Inventor), Sakari Kauppinen (Inventor), Andreas Petri (Inventor), Charlotte Albæk Thrue (Inventor)

Research output: Patent

Abstract

The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.

Original language	English
IPC	C12N 15/ 113 A I
Patent number	WO2018085656
Filing date	11/05/2018
Country/Territory	Denmark
Priority date	03/11/2016
Priority number	US201662416993P
Publication status	Published - 2018

Access to Document

https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20180511&CC=WO&NR=2018085656A1&KC=A1

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

@misc{cce5ad290e5b4078ad8df938d95ac688,

title = "Antisense oligomers targeting HOXB-AS3 lon non-coding RNA",

abstract = "The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.",

author = "Ramiro Garzon and Adrienne Dorrance and Dimitrios Papaioannou and Robert Lee and Sakari Kauppinen and Andreas Petri and {Alb{\ae}k Thrue}, Charlotte",

year = "2018",

language = "English",

type = "Patent",

note = "WO2018085656; C12N 15/ 113 A I",

}

TY - PAT

T1 - Antisense oligomers targeting HOXB-AS3 lon non-coding RNA

AU - Garzon, Ramiro

AU - Dorrance, Adrienne

AU - Papaioannou, Dimitrios

AU - Lee, Robert

AU - Kauppinen, Sakari

AU - Petri, Andreas

AU - Albæk Thrue, Charlotte

PY - 2018

Y1 - 2018

N2 - The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.

AB - The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.

M3 - Patent

M1 - WO2018085656

Y2 - 2018/05/11

ER -

Antisense oligomers targeting HOXB-AS3 lon non-coding RNA

Abstract

Access to Document

AUB Link

Fingerprint

Cite this